1. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
   Yuan Cheng et al, 2019, Signal Transduction and Targeted Therapy CrossRef
2. The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology
   Kazem Nejati-Koshki et al, 2023, Cancers CrossRef
3. Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon, and prostate
   Somnath Pandey et al, 2017, Biochemistry and Cell Biology CrossRef
4. Methylated Nucleotide-Based Proteolysis-Targeting Chimera Enables Targeted Degradation of Methyl-CpG-Binding Protein 2
   Zhen Wang et al, 2023, Journal of the American Chemical Society CrossRef
5. MECP2 expression in gastric cancer and its correlation with clinical pathological parameters
   Jing Zhang et al, 2017, Medicine CrossRef
6. Genomic and regulatory characteristics of significant transcription factors in colorectal cancer metastasis
   Bin Zhou et al, 2018, Scientific Reports CrossRef
7. Evaluation of Diagnostic and Prognostic Value of hsa_circ_0084927 and Analysis of Associated ceRNA Network in Colorectal Cancer
   Yi Chen et al, 2022, International Journal of General Medicine CrossRef
8. Zinc Finger E-Box Binding Homeobox Family: Non-Coding RNA and Epigenetic Regulation in Gliomas
   Bartosz Lenda et al, 2023, Biomedicines CrossRef
9. Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N6‐methyladenosine methylation through methyltransferase‐like 14
   Shuo Wang et al, 2021, Cancer Science CrossRef